(225 ILCS 85/42)
(Section scheduled to be repealed on January 1, 2023)
A pharmacist or her or his authorized employee must inform customers of a less expensive, generically equivalent drug product for her or his prescription and whether the cost-sharing obligation to the customer exceeds the retail price of the prescription in the absence of prescription drug coverage.
(Source: P.A. 101-452, eff. 1-1-20